MOH — authorised 22 December 1997
- Marketing authorisation holder: ABBVIE
- Status: likely_approved
🇮🇱 Teveten in Israel
MOH authorised Teveten on 22 December 1997
Marketing authorisation
Teveten in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Israel
Frequently asked questions
Is Teveten approved in Israel?
Yes. MOH authorised it on 22 December 1997.
Who is the marketing authorisation holder for Teveten in Israel?
ABBVIE holds the Israeli marketing authorisation.